Abingdon Health plc (AIM: ABDX), a leading international medical device contract development and manufacturing organisation (CDMO), announces it has signed a lease to open a commercial office and laboratory in Madison,
Abingdon Health PLC (AIM: ABDX) Results of the Retail Offer
Completion of Retail Offer
Abingdon Health PLC (AIM:ABDX) Annual Revenue Growth of 52%, Cashflow Positive in Q4
The board anticipates continued solid revenue growth in FY 2025
Abingdon Health PLC (AIM:ABDX) Design freeze completion & strategic partnership
Four sexually transmitted disease lateral flow self-tests complete design freeze.
Abingdon Health PLC (AIM:ABDX) Launch of OEM self-tests in Boots
Launch of OEM self-tests in Boots
Abingdon Health PLC (AIM:ABDX) Interim Results
Interim Results for the six months ended 31 December 2023
Zak Mir talks to Adrian Kinkaid, CEO (AIM:FAB) Fusion Antibodies
Fusion Antibodies plc (AIM: FAB), as the Early Discovery Contract Research Organisation specialising in pre-clinical antibody discovery, announces its unaudited interim results for the six months ended 30 September 2023
Abingdon Health PLC (AIM:ABDX) Final Results
York, U.K. 17 October 2023: Abingdon Health plc (AIM: ABDX), a leading international lateral flow contract research (CRO) and contract development and manufacturing organisation (CDMO), announces its final results for the
Tiziana’s lead candidate shows positive safety profile and clinical response
Tiziana Life Science Ltd is a biopharmaceutical firm in the clinical stage that develops breakthrough therapies by utilizing transformational drug-delivery technologies.
Abingdon Health PLC (AIM:ABDX) Salistick™ to be launched in Tesco
Salistick™, the first ever saliva pregnancy test, to be launched in Tesco
Abingdon Health PLC (AIM:ABDX) Launch of Salistick™ saliva pregnancy test
Superdrug to sell Salistick™, the first ever saliva pregnancy test, initially in 400 stores and online Salistick™ also to launch on the Abingdon Simply Test website
Abingdon Health PLC (AIM:ABDX) Senzo and Abingdon Health enter into strategic partnership
Abingdon Health’s CDMO service to support Senzo in leveraging its innovative, high-accuracy Amplified Lateral Flow (ALF) point-of-care diagnostics platform technology across multiple product opportunities